Stock Analysts’ updated eps estimates for Wednesday, November 19th:
Actuate Therapeutics (NASDAQ:ACTU) had its buy rating reissued by analysts at HC Wainwright. They currently have a $20.00 price target on the stock.
Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by analysts at Royal Bank Of Canada from an outperform rating to a sector perform rating. They currently have $28.00 target price on the stock.
AppFolio (NASDAQ:APPF) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $325.00 price target on the stock.
Aptiv (NYSE:APTV) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $101.00 target price on the stock.
Artelo Biosciences (NASDAQ:ARTL) had its hold rating reissued by analysts at Maxim Group.
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its buy rating reiterated by analysts at Chardan Capital. The firm currently has a $60.00 price target on the stock.
BellRing Brands (NYSE:BRBR) had its buy rating reiterated by analysts at DA Davidson. They currently have a $58.00 price target on the stock.
BellRing Brands (NYSE:BRBR) had its neutral rating reissued by analysts at Bank of America Corporation. The firm currently has a $28.00 price target on the stock, down from their previous price target of $50.00.
Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reiterated by analysts at Jefferies Financial Group Inc..
Canaan (NASDAQ:CAN) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $4.00 price target on the stock.
Cognition Therapeutics (NASDAQ:CGTX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $3.00 target price on the stock.
Canadian Solar (NASDAQ:CSIQ) had its underperform rating reissued by analysts at Mizuho. The firm currently has a $21.00 target price on the stock, up from their previous target price of $15.00.
DoorDash (NASDAQ:DASH) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $280.00 price target on the stock.
DraftKings (NASDAQ:DKNG) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $52.00 target price on the stock.
Eversource Energy (NYSE:ES) was downgraded by analysts at Wells Fargo & Company from an overweight rating to an equal weight rating. Wells Fargo & Company currently has $63.00 price target on the stock.
Elastic (NYSE:ESTC) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $130.00 price target on the stock.
FTAI Aviation (NASDAQ:FTAI) had its buy rating reiterated by analysts at BTIG Research. They currently have a $230.00 price target on the stock.
GoHealth (NASDAQ:GOCO) had its market perform rating reissued by analysts at William Blair.
GitLab (NASDAQ:GTLB) had its hold rating reiterated by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $44.00 target price on the stock, down from their previous target price of $55.00.
Interparfums (NASDAQ:IPAR) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a $123.00 price target on the stock.
Kairos Pharma (NYSEAMERICAN:KAPA) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $9.00 price target on the stock.
Lightspeed Commerce (NYSE:LSPD) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $16.00 price target on the stock.
Makita (OTCMKTS:MKTAY) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Modine Manufacturing (NYSE:MOD) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $200.00 price target on the stock.
Topgolf Callaway Brands (NYSE:MODG) had its buy rating reissued by analysts at Roth Capital. Roth Capital currently has a $14.00 target price on the stock.
Microsoft (NASDAQ:MSFT) had its buy rating reiterated by analysts at JPMorgan Chase & Co..
Microsoft (NASDAQ:MSFT) had its buy rating reaffirmed by analysts at Royal Bank Of Canada.
Netflix (NASDAQ:NFLX) had its buy rating reissued by analysts at Sanford C. Bernstein.
Powell Industries (NASDAQ:POWL) had its buy rating reissued by analysts at Roth Capital. Roth Capital currently has a $350.00 target price on the stock.
PVH (NYSE:PVH) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $95.00 target price on the stock.
Qfin (NASDAQ:QFIN) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $21.00 target price on the stock, down from their previous target price of $45.00.
Rocket Companies (NYSE:RKT) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $25.00 price target on the stock.
Revolve Group (NYSE:RVLV) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $30.00 target price on the stock.
Reviva Pharmaceuticals (NASDAQ:RVPH) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $2.00 target price on the stock.
Star Bulk Carriers (NASDAQ:SBLK) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a $22.00 target price on the stock.
Semrush (NASDAQ:SEMR) had its sector weight rating reissued by analysts at KeyCorp.
Tanger (NYSE:SKT) had its neutral rating reaffirmed by analysts at Citigroup Inc.. The firm currently has a $35.00 target price on the stock, down from their previous target price of $38.00.
Protara Therapeutics (NASDAQ:TARA) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $23.00 price target on the stock.
Target (NYSE:TGT) had its neutral rating reiterated by analysts at Roth Capital. The firm currently has a $90.00 target price on the stock.
TIM (NYSE:TIMB) had its hold rating reissued by analysts at Jefferies Financial Group Inc..
TJX Companies (NYSE:TJX) had its outperform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $155.00 price target on the stock.
Upwork (NASDAQ:UPWK) had its market outperform rating reissued by analysts at Citizens Jmp. They currently have a $27.00 target price on the stock.
Upwork (NASDAQ:UPWK) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $25.00 target price on the stock.
Urban Outfitters (NASDAQ:URBN) had its market perform rating reissued by analysts at Telsey Advisory Group. They currently have a $80.00 price target on the stock.
Vanda Pharmaceuticals (NASDAQ:VNDA) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $20.00 price target on the stock.
Varex Imaging (NASDAQ:VREX) had its buy rating reiterated by analysts at B. Riley. The firm currently has a $16.00 target price on the stock.
Young & Co.’s Brewery, P.L.C. (LON:YNGA) had its buy rating reissued by analysts at Panmure Gordon. They currently have a GBX 1,450 target price on the stock.
Receive News & Ratings for Actuate Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Actuate Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
